Vantus Wealth’s Pfizer PFE Stock Holding History

Vantus Wealth’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$547K	Buy	+22,727	New	+$595K	0.29%	107
2025 Q4	$467K	Buy	+18,748	New	+$473K	0.34%	89

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vantus Wealth's PFE Position: Q2 2026 in Review

Vantus Wealth opened a new position in Pfizer (PFE) in Q2 2026: 22,727 shares worth $547K. The stake represents 0.29% of the portfolio and ranks #107 among its holdings. This is a return to the name: Vantus Wealth previously reported a position in PFE as recently as Q4 2025.

Vantus Wealth first reported a position in PFE in Q4 2025 and has held it in 2 quarters since. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Vantus Wealth held 22,727 shares of Pfizer worth $547K as of Q2 2026.
Pfizer was a new Vantus Wealth position in Q2 2026.
Pfizer made up 0.29% of Vantus Wealth's portfolio in Q2 2026, its #107 holding.
Vantus Wealth first reported a position in Pfizer in Q4 2025 and has held it in 2 quarters since.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vantus Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.